Literature DB >> 7899790

Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials.

S Winkler1, C Brandts, W H Wernsdorfer, W Graninger, U Bienzle, P G Kremsner.   

Abstract

The sensitivity of Plasmodium falciparum to chloroquine, mefloquine, quinine, halofantrine, and sulfadoxine/pyrimethamine has been investigated at Lambaréné, in the Gabonese rain forest, between April and September 1992. WHO standard micro in vitro tests were performed. Of 43 isolates tested for response to chloroquine all were resistant to the drug with mean EC 50 and EC 90 values of 1.86 and 4.18 mumol/l blood, respectively, indicating the highest degree of resistance ever reported from Central Africa. With sulfadoxine/pyrimethamine 19 out of 27 isolates showed 90% inhibition of schizont maturation at a pyrimethamine concentration of at least 75 nmol/l blood medium mixture, indicating 30% of resistance to sulfadoxine/pyrimethamine. In contrast all isolates tested were fully inhibited by mefloquine at 3.2 mumol/l blood (40 isolates), quinine at 5.12 mumol/l blood medium mixture (41 isolates) and halofantrine at 3 nmol/l blood medium mixture (40 isolates) indicating full sensitivity to these drugs. A significant positive correlation was found between responses to quinine and mefloquine. The response to halofantrine was positively correlated with the responses to quinine and mefloquine, in the case of chloroquine and halofantrine an inverse relationship was observed. Compared with previous data from Gabon, the findings suggest a substantial increase of chloroquine resistance, in contrast to reports from neighbouring countries, which show stabilising or even declining chloroquine resistance patterns.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899790

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  11 in total

1.  Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.

Authors:  Denise P Mawili-Mboumba; Jürgen F J Kun; Bertrand Lell; Peter G Kremsner; Francine Ntoumi
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.

Authors:  Sunny Oyakhirome; Saadou Issifou; Peter Pongratz; Fortune Barondi; Michael Ramharter; Jürgen F Kun; Michel A Missinou; Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

3.  In vitro activity of antifungal drugs against Plasmodium falciparum field isolates.

Authors:  Peter Pongratz; Florian Kurth; Ghyslain Mombo Ngoma; Arti Basra; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2011-07-07       Impact factor: 1.704

4.  Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.

Authors:  J F Kun; L G Lehman; B Lell; R Schmidt-Ott; P G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Short course of quinine plus a single dose of sulfadoxine/pyrimethamine for Plasmodium falciparum malaria.

Authors:  Pierre-Blaise Matsiegui; Michel A Missinou; Magdalena Necek; Saadou Issifou; Peter G Kremsner
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

6.  No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria.

Authors:  Pembe Issamou Mayengue; Yvonne Kalmbach; Saadou Issifou; Peter G Kremsner; Francine Ntoumi
Journal:  Parasitol Res       Date:  2006-10-28       Impact factor: 2.289

7.  Fosmidomycin, a novel chemotherapeutic agent for malaria.

Authors:  Bertrand Lell; Ronnatrai Ruangweerayut; Jochen Wiesner; Michel Anoumou Missinou; Andreas Schindler; Thomas Baranek; Martin Hintz; David Hutchinson; Hassan Jomaa; Peter Gottfried Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.

Authors:  B Pradines; A Tall; T Fusai; A Spiegel; R Hienne; C Rogier; J F Trape; J Le Bras; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

9.  High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.

Authors:  Ghyslain Mombo-Ngoma; Sunny Oyakhirome; Rosalynn Ord; Julian J Gabor; Katja C Greutélaers; Katharina Profanter; Benedikt Greutélaers; Florian Kurth; Bertrand Lell; Jürgen F J Kun; Saadou Issifou; Cally Roper; Peter G Kremsner; Martin P Grobusch
Journal:  Malar J       Date:  2011-05-14       Impact factor: 2.979

10.  In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.

Authors:  Florian Kurth; Peter Pongratz; Sabine Bélard; Benjamin Mordmüller; Peter G Kremsner; Michael Ramharter
Journal:  Malar J       Date:  2009-04-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.